Abiopharma

Safe Pro Awarded New $1.3 Million U.S. Army Subcontract to Integrate Real-Time AI Landmine Detection into Unmanned Ground Vehicles

LQR House in Advanced Negotiations with ByteDance Across Its Artificial Intelligence Vertical

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Ameresco to Deliver Smart Water Metering infrastructure to Texas Municipal Utilities to Improve Operational Efficiency and Customer Service

BALLARD ANNOUNCES ACQUISITION OF UK-BASED GEOPURA, POWERING FUTURE GROWTH AND TRANSFORMING BALLARD INTO AN INTEGRATED HYDROGEN ECOSYSTEM PROVIDER

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

CrowdStrike Named a Leader in the 2026 IDC MarketScape for Worldwide SIEM

Calidi Biotherapeutics - Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer